3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow AST-120: new trials by email Literature Review of AST-120 trials Research Report on AST-120
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1) Placebo, AST-120 - Chronic Kidney Disease | Phase 3 | Completed | Tanabe Pharma Corporation | 1020 | 2007-07-01 | 2026-01-08 |
| A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2) Placebo, AST-120 - Chronic Kidney Disease | Phase 3 | Completed | Tanabe Pharma Corporation | 1015 | 2007-07-01 | 2026-01-08 |
| Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas AST-120 - Inflammatory Bowel Disease, Intestinal Fistula | Phase 3 | Completed | Ocera Therapeutics | 191 | 2006-03-01 | 2014-05-30 |
Kidney Diseases (2) · Renal Insufficiency, Chronic (2) · Crohn Disease (1) · Fistula (1) · Inflammatory Bowel Diseases (1) · Intestinal Fistula (1)
Tanabe Pharma Corporation (2) · Ocera Therapeutics (1)
Canada (3) · Czechia (3) · Poland (3) · United States (3) · Argentina (2) · Brazil (2) · France (2) · Germany (2) · Mexico (2) · Puerto Rico (2) · Russia (2) · Ukraine (2) · Austria (1) · Belgium (1) · Hungary (1)